Wednesday, May 11 2022 / 10am - 11am (Malaysia Time)
Assisted reproductive technologies bring good news to many infertile couples, as around 14% of couples of reproductive ages are having issues getting pregnant and having offspring of their own. The generalized in-vitro fertilization (IVF) approaches have only 25-30% live birth success rates per started cycle. Therefore, there is a lot of room for improvement in reproductive medicine. One of the most promising measures is precision medicine by incorporating new technologies such as next-generation sequencing, time-lapse imaging, genomics, and artificial intelligence. To date, precision medicine has already been widely accepted and implicated in reproductive medicine, both locally and internationally. However, this field is still facing severe challenges. For example, the number of people facing fertility disorders increases gradually, with various reasons and indications for infertility. Hence, the adoption of precision medicine in the reproductive area can be more conducive, with enhancements in biomarker-based diagnosis, healthy embryo identification, treatment processes, and many other aspects. In this talk, the current applications and potential of next-generation sequencing and genetic testing for personalized reproductive medicine will be introduced and discussed.